SPECT Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
| Line 23: | Line 23: | ||
==Reference Materials== | ==Reference Materials== | ||
*[[Media:I-123 DAT SCAN: Acquisition and Reconstruction Task Force.pdf | I-123 DAT SCAN: Acquisition and Reconstruction Task Force presentation slides | *[[Media:I-123 DAT SCAN: Acquisition and Reconstruction Task Force.pdf | I-123 DAT SCAN: Acquisition and Reconstruction Task Force presentation slides (Dr. Dewaraja)]] ''January 5, 2016'' | ||
*[[Media:Acquisition Process.pdf | Acquisition Processes for SPECT - Drs. Dewaraja, Frey, and Iida (notes)]] ''December 8, 2015'' | *[[Media:Acquisition Process.pdf | Acquisition Processes for SPECT - Drs. Dewaraja, Frey, and Iida (notes)]] ''December 8, 2015'' | ||
Revision as of 20:54, 6 January 2016
Project Snapshot
The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.
Under consideration:
- quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)
- quantifying organs, like the liver, for dosimetry as potential use cases
Meetings/Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Reference Materials
- I-123 DAT SCAN: Acquisition and Reconstruction Task Force presentation slides (Dr. Dewaraja) January 5, 2016
- QIBA Claim Statement Types - Dr. Obuchowski November 20, 2015
- 03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg:
- The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A